Loading…
Back To Schedule
Monday, June 26 • 4:15pm - 5:15pm
#153: The True Decentralization of Clinical Trials: Benefits and Drawbacks of Blockchain Technology

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Session
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-23-542-L04-P; CME 1.00; RN 1.00

This session focuses on how blockchain technology can enhance patient-experience, engagement, and retention in clinical trials. This will include a discussion of the potential benefits of blockchain, such as increasing transparency and security, as well as the challenges and limitations of implementation. Next, this presentation covers the implementation strategies for decentralized clinical trials to ensure end-to-end data integrity and risk mitigation purposes. This will provide insights on how blockchain technology can be used to improve the integrity of data collected during clinical trials, as well as to mitigate the risks commonly associated with centralized data management. Finally, the presentation will address ethical, governance, and self-sovereign identity benefits and drawbacks of blockchain technology. Presenters will provide identity management solutions and perspectives on individual’s wishes to gain visibility to (appropriate) data from their research participation. Overall, this presentation will offer a valuable opportunity to explore the potential of blockchain technology to enhance clinical trial processes, while also highlighting operational, regulatory, and ethical considerations that must be taken into account.

Learning Objectives

Recognize how blockchain can enhance patient experience, engagement, and retention in clinical trials; Determine decentralized clinical trial implementation strategies for end-to-end data integrity and risk mitigation purposes; Identify unique ethical, governance, and self-sovereign identity benefits and drawbacks of blockchain technology.

Chair

Wendy Charles, PhD

Speaker

The True Decentralization of Clinical Trials: Demonstrating the Real Implications of Blockchain and Self-Sovereign Identity
Joost Flach, PhD

Benefits and Drawbacks of Blockchain Technology for Clinical Trial Retention and the Patient Experience
Aman Khera, MBA


Speakers
avatar for Wendy Charles

Wendy Charles

Chief Ethics and Compliance Officer; Adjunct Faculty, Equideum Health, United States
Dr. Wendy Charles has been involved in clinical trials from every perspective for nearly 30 years with a strong background in operations and compliance of digital health technologies. She currently serves as Chief Scientific Officer for BurstIQ, a health IT company specializing in... Read More →
avatar for Joost Flach

Joost Flach

Co-founder and Head of eClinical Operations, Triall, Netherlands
Prior to co-founding Triall, Joost has worked as clinical research scientist and project manager at CR2O, a full-service clinical CRO specialized in managing complex studies. Joost holds a PhD in microbiology and is responsible for ensuring all digital innovations at Triall meet end-user... Read More →
avatar for Aman Khera

Aman Khera

Vice President, Regulatory Science, Strategy & Innovation, Worldwide Clinical Trials, Canada
Aman Khera has earned her nickname: Rebel Regulator, a clinical research professional, with over 28 years of experience in life sciences clinical research, advising biotech and pharma companies. With a deep foundation in global regulatory affairs and the life sciences industry, Aman... Read More →

Monday June 26, 2023 4:15pm - 5:15pm EDT
Room 253 A Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA
  03: Data-Tech, Session